Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (704)	1/28/2005 5:55:04 PM
From: Jibacoa	Read Replies (2) of 3722

Mike: Re: GLGC The stock seems oversold at present. It is trading at a new 54wks L and below the level where the insiders reportedly bought last August. As I previously mentioned,the revenues on the last 2Qs have been 4% lower compared to previous year and it has had a higher loss for the 3Qs, especially the last.(Sep.) As I said, I don't know if GLGC will meet expectations for the Dec.Q since the total loss for the current year is $0.68 and the 9 month loss is already $0.78. (In 2003 the last Q loss was $0.16) In order for the EE loss to be correct, it would have to report earnings on the black column of $0.10/share, which seems unlikely. I also didn't understand well their deal with AFFX for 2005. The current price is below its reported cash/share,($3.35) and its Debt/Equity ratio 0.006 doesn't look bad. Looking at its Hs & Ls in the last 8 years, the lowest H was last year (Mar.5 at $6.04) before that it always traded at $8 or higher sometime during the year.<g> As mentioned, the present L is below last Aug.($3.15) and it is the lowest since 1998. Unless you expect the stock to make a V bottom, it seems wise to wait for the stock to try to make a "base" at present levels and for the last Q earnings to come out before trying to add to your position, especially since it is usually not a good thing to "average down".<g>(The stock needs to close above $3.20 in order to get off its present near term down trend) Bottom line: The stock looks cheap at present levels and it seems to have a chance for a 100% gain from present levels in the next 12 months unless the general market continues to deteriorate. We certainly have had a very negative "JANUARY EFFECT" this year.<g>(Just in case is good to keep some cash handy.) RAGL Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next